Identification of targeted therapies for rare adult mature T-cell leukemia using functional ex vivo screening of primary patient samples.
Oregon Health and Science University, Knight Cancer Institute.
Uma
http://orcid.org/0000-0002-4958-4962
U
Borate
Oregon Health and Science University, Knight Cancer Institute.
Brianna A
BA
Norris
Oregon Health and Science University, Knight Cancer Institute.
Pierrette
P
Lo
Oregon Health and Science University, Knight Cancer Institute.
Cristina
C
Tognon
Oregon Health and Science University, Knight Cancer Institute.
Jeffrey
J
Tyner
Oregon Health and Science University, Knight Cancer Institute.
Stephen
S
Spurgeon
D000368:Aged; D000369:Aged, 80 and over; D000074323:Alemtuzumab / Q000008:administration & dosage*; D018572:Disease-Free Survival; D005260:Female; D006801:Humans; D015461:Leukemia, Prolymphocytic, T-Cell / Q000188:drug therapy / Q000378:metabolism / Q000401:mortality / Q000473:pathology; D008297:Male; D008875:Middle Aged; D015996:Survival Rate
D000074323:Alemtuzumab